Globeflex Capital »

Aurinia Pharmaceuticals shares owned by Globeflex Capital

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $186k 12k 15.95

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Exelixis (EXEL)
Copa Holdings Sa-class A (CPA)
Universal Health Services (UHS)
Tenet Healthcare Corporation (THC)
NCR Atleos Corp (NATL)
Rigel Pharmaceuticals (RIGL)
Blue Bird Corp (BLBD)
Cirrus Logic (CRUS)
EnerSys (ENS)
Allegheny Technologies Incorporated (ATI)
Marex Group (MRX)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Ypf Sa (YPF)
Ibex (IBEX)

View all positions for Globeflex Capital

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Renaissance Technologies
Marshall Wace
Geode Capital Management
Jane Street
Vanguard Group
Two Sigma Investments
Jacobs Levy Equity Management
Henderson Group
Goldman Sachs Group
Citadel Advisors

View all funds holding Aurinia Pharmaceuticals